Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Submitted by
admin
on December 3, 2014 - 8:05am
Source:
Bidness Etc.
News Tags:
Idera Pharmaceuticals
IMO-2055
Yervoy
cancer
Headline:
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Do Not Allow Advertisers to Use My Personal information
